Study period | ||||||
---|---|---|---|---|---|---|
Baseline | Day 3 | Day 5 | 1 month | 6 month | 12 month | |
ENROLMENT | ||||||
Eligibility screen | X | |||||
Informed consent | X | |||||
Screening log | X | |||||
Randomisation | X | |||||
ASSESSMENT | ||||||
Assessment form | X | X | X | X | X | X |
Demographics | X | |||||
Presenting problem | X | |||||
Place of assessment | X | X | X | X | X | X |
Patient status (‘living at home’) | X | X | X | X | X | |
Subsequent admissions | X | X | ||||
Adverse event log | X | X | X | X | X | |
QUESTIONNAIRES | ||||||
Barthel Index of Activities of Daily Living | X | X | ||||
Confusion Assessment Method (CAM) | X | X | X | X | ||
Charlson Co-morbidity Index | X | X | ||||
Health Service Use Questionnaire | X | X | ||||
Short Form of the Informant Questionnaire on Cognitive Decline in the Elderly (Short IQCODE) | X | |||||
Montreal Cognitive Assessment (MoCA) | X | X | ||||
EuroQol five-dimension five-level (EQ-5D-5 L) | X | X | ||||
Patient feedback form | X | |||||
Difficulties in Questionnaire completion Form | X | X | X | X | X | |
MISCELLANEOUS | ||||||
Death form | Completed on patient death | |||||
Discontinuation form | Completed when a patient withdraws or is lost to follow-up |